Sector · Sep 2026
Healthcare
What mutual funds hold in Healthcare companies, what they bought and sold, and which fund houses lean on the sector most.
Data periodHoldings monthSep 2026NSE prices23 Oct 2026Data status →
At the end of Sep 2026, mutual funds held ₹4.08 lakh Cr of Healthcare shares across 67 companies — 8.2% of all the equity they disclosed (+0.16 pp on the month).
Funds were estimated net buyers of ₹6,992 Cr: they added to 38 of these companies and cut 29. Over the 12 months to Sep 2026, estimated net buying adds up to +23,870 Cr.
Estimated buying, month by month
Net ₹ crore · same schemes, month-end prices
Loading history…
Share of all fund equity
Per cent of disclosed equity, by value
Loading history…
Value held also moves with the number of fund houses disclosing each month; the share is the steadier guide.
Bought most
Estimated net buying in Sep 2026
- Divi's Laboratories Limited41 fund houses₹1,297 Cr
- Zydus Lifesciences Limited33 fund houses₹1,120 Cr
- Sun Pharmaceutical Industries Limited37 fund houses₹1,114 Cr
- Dr. Reddy's Laboratories Limited31 fund houses₹863 Cr
- Gland Pharma Limited25 fund houses₹769 Cr
- Biocon Limited33 fund houses₹753 Cr
- Cipla Limited36 fund houses₹541 Cr
- Apollo Hospitals Enterprise Limited38 fund houses₹395 Cr
Sold most
Estimated net selling in Sep 2026
- Glenmark Pharmaceuticals Limited32 fund houses₹460 Cr
- Anthem Biosciences Limited25 fund houses₹281 Cr
- Piramal Pharma Limited22 fund houses₹103 Cr
- Sai Life Sciences Limited25 fund houses₹99.24 Cr
- Wockhardt Limited20 fund houses₹92.40 Cr
- Krishna Institute of Medical Sciences Limited24 fund houses₹90.21 Cr
- Pfizer Limited12 fund houses₹70.04 Cr
- Cohance Lifesciences Limited19 fund houses₹59.71 Cr
Every company funds hold
67 companies · Sep 2026
| Company | Size | Value held | Estimated net buying | Fund houses | Adding | Cutting |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries LimitedSUNPHARMA | Large Cap | 52,395 Cr | +1,114 Cr | 37 | 129 | 106 |
| Divi's Laboratories LimitedDIVISLAB | Large Cap | 33,522 Cr | +1,297 Cr | 41 | 104 | 71 |
| Cipla LimitedCIPLA | Large Cap | 21,510 Cr | +541 Cr | 36 | 101 | 88 |
| Apollo Hospitals Enterprise LimitedAPOLLOHOSP | Large Cap | 18,872 Cr | +395 Cr | 38 | 101 | 101 |
| Max Healthcare Institute LimitedMAXHEALTH | Large Cap | 16,567 Cr | +281 Cr | 33 | 99 | 78 |
| Dr. Reddy's Laboratories LimitedDRREDDY | Large Cap | 15,832 Cr | +863 Cr | 31 | 110 | 53 |
| Aurobindo Pharma LimitedAUROPHARMA | Mid Cap | 15,168 Cr | -16.86 Cr | 37 | 64 | 62 |
| Torrent Pharmaceuticals LimitedTORNTPHARM | Large Cap | 13,754 Cr | +210 Cr | 36 | 105 | 72 |
| Lupin LimitedLUPIN | Mid Cap | 12,910 Cr | -58.48 Cr | 32 | 75 | 56 |
| Gland Pharma LimitedGLAND | Small Cap | 12,896 Cr | +769 Cr | 25 | 34 | 48 |
| IPCA Laboratories LimitedIPCALAB | Mid Cap | 12,048 Cr | +40.23 Cr | 26 | 39 | 47 |
| Fortis Healthcare LimitedFORTIS | Mid Cap | 12,010 Cr | -46.18 Cr | 34 | 60 | 68 |
| Biocon LimitedBIOCON | Mid Cap | 11,351 Cr | +753 Cr | 33 | 61 | 56 |
| Mankind Pharma LimitedMANKIND | Mid Cap | 11,106 Cr | +109 Cr | 30 | 52 | 50 |
| Alkem Laboratories LimitedALKEM | Mid Cap | 10,385 Cr | +179 Cr | 28 | 87 | 24 |
| Aster DM Quality Care LimitedASTERDM | Small Cap | 10,051 Cr | +265 Cr | 28 | 39 | 18 |
| Glenmark Pharmaceuticals LimitedGLENMARK | Mid Cap | 9,377 Cr | -460 Cr | 32 | 56 | 74 |
| Sai Life Sciences LimitedSAILIFE | Small Cap | 9,254 Cr | -99.24 Cr | 25 | 28 | 55 |
| Laurus Labs LimitedLAURUSLABS | Mid Cap | 8,367 Cr | -39.69 Cr | 31 | 76 | 66 |
| Krishna Institute of Medical Sciences LimitedKIMS | Small Cap | 7,345 Cr | -90.21 Cr | 24 | 37 | 24 |
| Zydus Lifesciences LimitedZYDUSLIFE | Mid Cap | 6,559 Cr | +1,120 Cr | 33 | 64 | 61 |
| Ajanta Pharma LimitedAJANTPHARM | Small Cap | 6,558 Cr | -34.17 Cr | 29 | 75 | 26 |
| Dr. Lal Path Labs Ltd.LALPATHLAB | Small Cap | 6,003 Cr | +28.41 Cr | 31 | 30 | 39 |
| Global Health LimitedMEDANTA | Mid Cap | 4,571 Cr | -52.29 Cr | 25 | 68 | 19 |
| Abbott India LimitedABBOTINDIA | Mid Cap | 4,285 Cr | +23.66 Cr | 25 | 36 | 23 |
| Syngene International LimitedSYNGENE | Small Cap | 3,972 Cr | +75.11 Cr | 23 | 28 | 30 |
| Anthem Biosciences LimitedANTHEM | Mid Cap | 3,823 Cr | -281 Cr | 25 | 56 | 22 |
| Vijaya Diagnostic Centre LimitedVIJAYA | Small Cap | 3,676 Cr | -7.43 Cr | 23 | 19 | 31 |
| Piramal Pharma LimitedPPLPHARMA | Small Cap | 3,461 Cr | -103 Cr | 22 | 21 | 37 |
| Metropolis Healthcare LimitedMETROPOLIS | Small Cap | 3,267 Cr | +6.88 Cr | 19 | 11 | 13 |
| Narayana Hrudayalaya Ltd.NH | Mid Cap | 3,155 Cr | +4.24 Cr | 22 | 20 | 19 |
| Eris Lifesciences LimitedERIS | Small Cap | 2,941 Cr | -26.31 Cr | 15 | 5 | 12 |
| Neuland Laboratories LimitedNEULANDLAB | Small Cap | 2,857 Cr | -51.23 Cr | 28 | 22 | 28 |
| Acutaas Chemicals LimitedACUTAAS | Small Cap | 2,778 Cr | +50.56 Cr | 26 | 40 | 31 |
| Cohance Lifesciences LimitedCOHANCE | Small Cap | 2,773 Cr | -59.71 Cr | 19 | 22 | 32 |
| Rubicon Research LimitedRUBICON | Small Cap | 2,594 Cr | +23.14 Cr | 18 | 17 | 6 |
| Rainbow Childrens Medicare LimitedRAINBOW | Small Cap | 2,451 Cr | -37.41 Cr | 22 | 19 | 34 |
| GlaxoSmithKline Pharmaceuticals LimitedGLAXO | Mid Cap | 2,315 Cr | +59.66 Cr | 23 | 32 | 35 |
| Onesource Specialty Pharma LimitedONESOURCE | Small Cap | 2,299 Cr | +38.08 Cr | 21 | 17 | 28 |
| Pfizer LimitedPFIZER | Small Cap | 2,250 Cr | -70.04 Cr | 12 | 5 | 3 |
| Thyrocare Technologies LimitedTHYROCARE | Small Cap | 1,943 Cr | +2.95 Cr | 15 | 5 | 5 |
| Wockhardt LimitedWOCKPHARMA | Small Cap | 1,891 Cr | -92.40 Cr | 20 | 17 | 32 |
| Healthcare Global Enterprises LimitedHCG | Small Cap | 1,847 Cr | +110 Cr | 13 | 8 | 4 |
| Emcure Pharmaceuticals LimitedEMCURE | Small Cap | 1,744 Cr | -8.44 Cr | 20 | 41 | 4 |
| Poly Medicure LimitedPOLYMED | Small Cap | 1,652 Cr | -21.10 Cr | 19 | 17 | 28 |
| Indegene LimitedINDGN | Small Cap | 1,601 Cr | -29.53 Cr | 15 | 6 | 11 |
| Jubilant Pharmova LimitedJUBLPHARMA | Small Cap | 1,281 Cr | +41.87 Cr | 13 | 8 | 8 |
| Strides Pharma Science LimitedSTAR | Small Cap | 1,071 Cr | +59.05 Cr | 8 | 6 | 5 |
| Granules India LimitedGRANULES | Small Cap | 939 Cr | +111 Cr | 22 | 39 | 25 |
| Akums Drugs and Pharmaceuticals LimitedAKUMS | Small Cap | 915 Cr | -57.80 Cr | 10 | 5 | 3 |
| Shilpa Medicare LimitedSHILPAMED | Small Cap | 860 Cr | -8.02 Cr | 12 | 3 | 12 |
| Procter & Gamble Health LimitedPGHL | Small Cap | 822 Cr | +18.26 Cr | 14 | 6 | 1 |
| Concord Biotech LimitedCONCORDBIO | Small Cap | 794 Cr | -53.42 Cr | 17 | 14 | 22 |
| Yatharth Hospital & Trauma Care Services LimitedYATHARTH | Small Cap | 463 Cr | -20.27 Cr | 7 | 4 | 4 |
| Senores Pharmaceuticals LimitedSENORES | Small Cap | 400 Cr | +41.99 Cr | 10 | 5 | 1 |
| Blue Jet Healthcare LimitedBLUEJET | Small Cap | 391 Cr | -7.65 Cr | 7 | 5 | 2 |
| Marksans Pharma LimitedMARKSANS | Small Cap | 390 Cr | -24.34 Cr | 9 | 3 | 10 |
| Caplin Point Laboratories LimitedCAPLIPOINT | Small Cap | 335 Cr | -16.32 Cr | 16 | 18 | 24 |
| Natco Pharma LimitedNATCOPHARM | Small Cap | 325 Cr | +56.16 Cr | 19 | 21 | 36 |
| Viyash Scientific LimitedVIYASH | Small Cap | 321 Cr | +112 Cr | 8 | 9 | 1 |
| Nephrocare Health Services LimitedNEPHROPLUS | Small Cap | 276 Cr | +73.23 Cr | 13 | 6 | 1 |
| Supriya Lifescience LimitedSUPRIYA | Small Cap | 75.23 Cr | +0.26 Cr | 8 | 3 | 1 |
| Aarti Pharmalabs LimitedAARTIPHARM | Small Cap | 49.63 Cr | +0.57 Cr | 9 | 3 | 2 |
| Park Medi World LimitedPARKHOSPS | Small Cap | 36.65 Cr | +1.98 Cr | 6 | 10 | 0 |
| Advanced Enzyme Technologies LimitedADVENZYMES | Small Cap | 35.01 Cr | -18.32 Cr | 7 | 3 | 4 |
| Suven Life Sciences LimitedSUVEN | Small Cap | 6.59 Cr | +6.49 Cr | 5 | 2 | 0 |
| Sun Pharma Advanced Research Company LimitedSPARC | Small Cap | 6.09 Cr | +0.20 Cr | 6 | 3 | 5 |
Fund houses that lean on Healthcare
Share of each fund house’s disclosed equity in this sector · all funds: 8.2%
| Fund house | Share of its equity | Versus all funds | Value held | Companies |
|---|---|---|---|---|
| Capitalmind Mutual Fund | 28.9% | +20.77 pp | 140 Cr | 13 |
| NJ Mutual Fund | 22.7% | +14.57 pp | 1,468 Cr | 22 |
| Samco Mutual Fund | 14.6% | +6.40 pp | 277 Cr | 25 |
| quant Mutual Fund | 14.4% | +6.26 pp | 12,038 Cr | 19 |
| Bajaj Finserv Mutual Fund | 12.5% | +4.36 pp | 2,661 Cr | 28 |
| WhiteOak Capital Mutual Fund | 12.3% | +4.13 pp | 4,027 Cr | 38 |
| TRUST Mutual Fund | 12.0% | +3.87 pp | 790 Cr | 18 |
| HDFC Mutual Fund | 11.2% | +3.00 pp | 65,776 Cr | 51 |
| Invesco Mutual Fund | 11.1% | +2.93 pp | 12,898 Cr | 26 |
| Axis Mutual Fund | 11.0% | +2.84 pp | 22,228 Cr | 48 |
| Mirae Asset Mutual Fund | 10.9% | +2.71 pp | 19,667 Cr | 66 |
| PGIM India Mutual Fund | 10.2% | +2.03 pp | 2,128 Cr | 22 |
Fund houses with at least ₹1 crore in the sector. A high share reflects the fund house’s scheme mix (sector and thematic funds) as much as a view.
Sector: NSE Indices industry classification. Values: disclosed quantities × official NSE closing prices. Estimates are not transaction records. Method →